<--- Back to Details
First PageDocument Content
Immunosuppressants / Monoclonal antibodies / Immunology / Biotechnology / Immune system / TNF inhibitor / Infliximab / Tocilizumab / Adalimumab / Tumor necrosis factor alpha / Natalizumab / Etanercept
Date: 2016-07-28 12:58:50
Immunosuppressants
Monoclonal antibodies
Immunology
Biotechnology
Immune system
TNF inhibitor
Infliximab
Tocilizumab
Adalimumab
Tumor necrosis factor alpha
Natalizumab
Etanercept

JULY 2016 TABLE OF CONTENTS INTRODUCTION

Add to Reading List

Source URL: www.abirisk.eu

Download Document from Source Website

File Size: 1,18 MB

Share Document on Facebook

Similar Documents

TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS REPORT BY THE DECISION SUPPORT UNIT Stephen Palmer, Mark Sculpher

DocID: 1s1AX - View Document

Medicine / Clinical medicine / Immunology / Immunosuppressants / RTT / Rheumatology / Orphan drugs / Specialty drugs / Tocilizumab / Autoimmunity / Rituximab / Rheumatoid arthritis

NOVEMBER 2015 TABLE OF CONTENTS INTRODUCTION

DocID: 1qUAB - View Document

Health economics / Healthcare quality / Immunosuppressants / Orphan drugs / Costs / Disease-modifying antirheumatic drug / Tocilizumab / Rituximab / Quality-adjusted life year / Rheumatoid arthritis / Etanercept / TNF inhibitor

TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

DocID: 1pnYX - View Document

Immunosuppressants / Monoclonal antibodies / Immunology / Biotechnology / Immune system / TNF inhibitor / Infliximab / Tocilizumab / Adalimumab / Tumor necrosis factor alpha / Natalizumab / Etanercept

JULY 2016 TABLE OF CONTENTS INTRODUCTION

DocID: 1pejO - View Document

Monoclonal antibodies / Immunosuppressants / Immunology / Biotechnology / Immune system / Adalimumab / Tocilizumab / Infliximab / Monoclonal antibody therapy / Disease-modifying antirheumatic drug / TNF inhibitor / Rheumatology

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1oMip - View Document